stella
beta
Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health — Stella
Recruiting
Back to HIV trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(6 sites)
United States
Bridge HIV, San Francisco Department of Public Health, San Francisco, California
Ponce de Leon Center CRS, Atlanta, Georgia
The Hope Clinic of the Emory Vaccine Research Center; Emory University, Decatur, Georgia
Brigham and Women's Hospital Vaccine CRS (BWH VCRS), Boston, Massachusetts
Columbia Physicians & Surgeons, New York, New York
Show all 6 locations
View full record on ClinicalTrials.gov